World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
70
Citations
37782
World Ranking
20041
National Ranking
1803

Overview

Eric L. Michelson is affiliated with AstraZeneca in the United Kingdom. Their professional background is connected to the pharmaceutical industry, based on the primary affiliation with a multinational biopharmaceutical company focused on scientific research and development.

There is no specific data available regarding published research papers, co-authors, or frequent publication venues. Similarly, there are no records of book publications or detailed information about the main fields or subfields of study related to Michelson's work.

Information on scientific topics or research areas that Michelson has extensively worked on is also not provided. Likewise, details about awards or honors are absent from the available data.

Owing to the nature of the affiliation, it is reasonable to associate Michelson's professional activities with pharmaceutical research, drug development, or related biomedical sciences; however, no explicit details confirm particular fields of specialization or research themes.

Best Publications

  • Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

    Christopher B Granger;John J V McMurray;Salim Yusuf;Peter Held

  • Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

    Salim Yusuf;Marc A Pfeffer;Karl Swedberg;Christopher B Granger

  • Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

    Marc A Pfeffer;Karl Swedberg;Christopher B Granger;Peter Held

  • Fast track — ArticlesEffects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

    Christopher B Granger;John Jv McMurray;Salim Yusuf;Peter Held

  • CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL

    J J Mcmurray;J Ostergren;K Swedberg;C B Granger

  • Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank.

    G. Michael Felker;Larry A. Allen;Stuart J. Pocock;Linda K. Shaw

  • Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker

    Stevo Julius;Shawna D. Nesbitt;Brent M. Egan;Michael A. Weber

  • Predictors of mortality and morbidity in patients with chronic heart failure

    Stuart J Pocock;Duolao Wang;Marc A Pfeffer;Salim Yusuf

  • Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure

    Hans L. Hillege;Dorothea Nitsch;Marc A. Pfeffer;Karl Swedberg

  • Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients

    Scott D Solomon;Nagesh Anavekar;Hicham Skali;John J V McMurray

  • Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency.

    J Morganroth;E L Michelson;L N Horowitz;M E Josephson

  • Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

    Michael R. MacDonald;Mark C. Petrie;Fumi Varyani;Jan Östergren

  • Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure.

    Scott D. Solomon;Joanna Dobson;Stuart Pocock;Hicham Skali

  • Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction : Results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program

    Lars G. Olsson;Karl Swedberg;Anique Ducharme;Christopher B. Granger

  • Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.

    L N Horowitz;M E Josephson;A Farshidi;S R Spielman

  • CHARM INVESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND PRESERVED LEFT-VENTRICULAR EJECTION FRACTION: THE CHARM-PRESERVED TRIAL

    S Yusuf;Pfeffer;K Swedberg;C B Granger

  • Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.

    Bradi B Granger;Karl Swedberg;Inger Ekman;Christopher B Granger

  • Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction Results of the CHARM Low-Left Ventricular Ejection Fraction Trials

    James B. Young;Mark E. Dunlap;Marc A. Pfeffer;Jeffrey L. Probstfield

  • Recurrent sustained ventricular tachycardia. 4. Pleomorphism.

    M E Josephson;L N Horowitz;A Farshidi;S R Spielman

  • Effects of candesartan on mortality and morbidity in patients with chronic heart failure

    MA Pfeffer;K Swedberg;CB Granger;P Held

Frequent Co-Authors

Salim Yusuf
Salim Yusuf McMaster University
Marc A. Pfeffer
Marc A. Pfeffer Harvard Medical School
John J.V. McMurray
John J.V. McMurray University of Glasgow
Karl Swedberg
Karl Swedberg University of Gothenburg
Christopher B. Granger
Christopher B. Granger Duke University
Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
Stuart J. Pocock
Stuart J. Pocock London School of Hygiene & Tropical Medicine
James B. Young
James B. Young Cleveland Clinic
Christopher P. Cannon
Christopher P. Cannon Brigham and Women's Hospital
Robert F. Storey
Robert F. Storey University of Sheffield

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical education in the USA opens doors to a range of online degree options and alternative career pathways. Many healthcare professionals consider bridging their credentials. For example, registered nurses often look into adn to fnp programs to advance their skills and become Family Nurse Practitioners. These pathways offer flexible online options for working professionals.

An online degree in nutrition is another popular choice, preparing graduates for careers in dietetics, public health, and wellness coaching. For those interested in the business side of healthcare, selecting a cahme-accredited online Master of Health Administration program ensures a rigorous and credible educational experience.

Nurses seeking additional credentials can benefit from flexible rn to bsn programs with no required clinicals, allowing them to enhance their qualifications entirely online. These related degrees are ideal for those aiming to expand their expertise or shift specialties within the healthcare field.

Best Scientists Citing Eric L. Michelson

Trending Scientists

Recently Published Articles